Skip to main content
Clinical Trials/NCT04585646
NCT04585646
Completed
Not Applicable

A Two-Week Crossover Dispensing Evaluation Of Orion Daily Wear Soft Contact Lens

Coopervision, Inc.1 site in 1 country64 target enrollmentSeptember 14, 2020
ConditionsMyopia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myopia
Sponsor
Coopervision, Inc.
Enrollment
64
Locations
1
Primary Endpoint
Subjective Response for Vision Satisfaction
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear.

Detailed Description

The primary objective of the study is to evaluate the clinical performance of test lens (Orion) in comparison with control lens (Gemini) over a period of two weeks of wear. This is a double-masked, randomized, bilateral, two-week crossover, dispensing study.

Registry
clinicaltrials.gov
Start Date
September 14, 2020
End Date
December 31, 2020
Last Updated
3 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Is at least 18 years of age and has full legal capacity to volunteer.
  • Is no greater than 55 years of age.
  • Has read and understood the information consent letter.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Is an adapted soft contact lens wearer having worn lenses for a minimum of 4 weeks prior to the study.
  • Has spectacle cylinder ≤1.00D in both eyes.
  • Has spherical contact lens power requirement between -1.00D and -6.00D in both eyes.
  • Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/20 in each eye.
  • Wears CLs in both eyes (monovision acceptable, but not monofit)
  • Has clear corneas and no active ocular disease.

Exclusion Criteria

  • Has never worn contact lenses before.
  • Has any systemic disease affecting ocular health.
  • Is using any systemic or topical medications that will affect ocular health.
  • Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
  • Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
  • Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
  • Is aphakic.
  • Has strabismus/amblyopia.
  • Has undergone corneal refractive surgery.
  • Is pregnant, lactating or planning a pregnancy.

Outcomes

Primary Outcomes

Subjective Response for Vision Satisfaction

Time Frame: Baseline - After 10 minutes of lens dispense

Subjective Response for Vision Satisfaction assessed on 7-point Likert (Very satisfied, Satisfied, Somewhat satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, Dissatisfied, Very Dissatisfied)

Subjective Response for Overall Vision Satisfaction

Time Frame: 2 Weeks - at night

Subjective Response for Vision satisfaction assessed on 7-point Likert (Very satisfied, Satisfied, Somewhat satisfied, Neither Satisfied nor Dissatisfied, Somewhat Dissatisfied, Dissatisfied, Very Dissatisfied)

Subjective Response for Overall Vision Quality

Time Frame: 2 weeks - Night Driving

Subjective Response for Overall Vision Quality assessed on a 0-100 scale (0- Unacceptable, 100- Excellent Vision)

Secondary Outcomes

  • Subjective Overall Lens Handling(2 weeks)
  • Post-blink Movement(2 weeks)
  • Lens Horizontal Mobility Rating(2 weeks)
  • Corneal Staining Extent(2 weeks)
  • Overall Lens Fit Acceptance(2 weeks)
  • Lens Handling Satisfaction(2 weeks)
  • Subjective Overall Comfort Satisfaction(2 Weeks)
  • Subjective Preference for Comfort(2 weeks)
  • Lens Surface Wettability Performance(2 weeks)
  • Horizontal Lens Centration(2 weeks)
  • Vertical Lens Centration(2 weeks)

Study Sites (1)

Loading locations...

Similar Trials